SYNEOS HEALTH CLINICAL, INC.

SYNEOS HEALTH CLINICAL, INC. is a clinical research organization that provides contract drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies in the United States and internationally. It offers Phase I-IIa clinical trial, Phase IIb-III clinical trial, late stage, strategic resourcing, bioanalytical, functional, flexible clinical staffing, permanent recruitment, quality assurance, and consulting services. The company also conducts clinical programs in oncology, cardiovascular, neuroscience, infectious diseases/vaccines, pain management, biosimilars, cell/gene/tissue therapies, generics, pediatrics, small molecule therapeutics, endocrinology/metabolism, rheumatology, respiratory/pulmonology, dermatology, ophthalmology, urology, nephrology, women’s health, and other therapeutic areas. In addition, it offers biostatistics, data management, project management, study monitoring, patient recruitment, and global safety and pharmacovigilance services for Phase IIb–III clinical trials. SYNEOS HEALTH CLINICAL, INC. was formerly known as inVentiv Health Clinical, Inc. and changed its name to SYNEOS HEALTH CLINICAL, INC. in August 2017. The company was founded in 1984 and is headquartered in Princeton, New Jersey with additional offices in the Asia Pacific, Europe, Latin America, and North America. SYNEOS HEALTH CLINICAL, INC. operates as a subsidiary of Syneos Health, Inc.